AZN logo

AstraZeneca PLC (AZN) Shareholders equity

annual shareholders equity:

$40.79B+$1.64B(+4.20%)
December 31, 2024

Summary

  • As of today (August 21, 2025), AZN annual stockholders equity is $40.79 billion, with the most recent change of +$1.64 billion (+4.20%) on December 31, 2024.
  • During the last 3 years, AZN annual shareholders equity has risen by +$1.52 billion (+3.87%).
  • AZN annual shareholders equity is now at all-time high.

Performance

AZN Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

quarterly shareholders equity:

$44.72B+$3.68B(+8.97%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN quarterly stockholders equity is $44.72 billion, with the most recent change of +$3.68 billion (+8.97%) on June 30, 2025.
  • Over the past year, AZN quarterly shareholders equity has increased by +$5.21 billion (+13.18%).
  • AZN quarterly shareholders equity is now at all-time high.

Performance

AZN quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

AZN Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.2%+13.2%
3 y3 years+3.9%+24.4%
5 y5 years+210.7%+265.4%

AZN Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+10.1%at high+27.3%
5 y5-yearat high+210.7%at high+266.7%
alltimeall timeat high>+9999.0%at high+1916.8%

AZN Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$44.72B(+9.0%)
Mar 2025
-
$41.04B(+0.6%)
Dec 2024
$40.79B(+4.2%)
$40.79B(+0.2%)
Sep 2024
-
$40.72B(+3.1%)
Jun 2024
-
$39.51B(+5.5%)
Mar 2024
-
$37.45B(-4.3%)
Dec 2023
$39.14B(+5.7%)
$39.14B(+5.2%)
Sep 2023
-
$37.20B(-0.5%)
Jun 2023
-
$37.39B(+4.5%)
Mar 2023
-
$35.79B(-3.4%)
Dec 2022
$37.04B(-5.7%)
$37.04B(+5.4%)
Sep 2022
-
$35.13B(-2.2%)
Jun 2022
-
$35.93B(-1.1%)
Mar 2022
-
$36.34B(-7.5%)
Dec 2021
$39.27B(+151.4%)
$39.27B(-1.2%)
Sep 2021
-
$39.74B(+153.5%)
Jun 2021
-
$15.68B(+8.6%)
Mar 2021
-
$14.43B(-7.6%)
Dec 2020
$15.62B(+19.0%)
$15.62B(+28.1%)
Sep 2020
-
$12.20B(-0.3%)
Jun 2020
-
$12.24B(+13.5%)
Mar 2020
-
$10.78B(-17.9%)
Dec 2019
$13.13B(+5.3%)
$13.13B(+7.9%)
Sep 2019
-
$12.16B(-10.2%)
Jun 2019
-
$13.55B(+29.2%)
Mar 2019
-
$10.48B(-15.9%)
Dec 2018
$12.47B(-16.7%)
$12.47B(+4.5%)
Sep 2018
-
$11.94B(-5.6%)
Jun 2018
-
$12.64B(-2.1%)
Mar 2018
-
$12.91B(-13.7%)
Dec 2017
$14.96B(+0.7%)
$14.96B(+9.0%)
Sep 2017
-
$13.72B(+0.5%)
Jun 2017
-
$13.65B(+5.1%)
Mar 2017
-
$12.99B(-12.6%)
Dec 2016
$14.85B(-19.7%)
$14.85B(+13.6%)
Sep 2016
-
$13.07B(-3.4%)
Jun 2016
-
$13.53B(-8.2%)
Mar 2016
-
$14.74B(-20.3%)
Dec 2015
$18.49B(-5.8%)
$18.49B(+6.6%)
Sep 2015
-
$17.35B(-5.1%)
Jun 2015
-
$18.28B(+7.9%)
Mar 2015
-
$16.94B(-13.7%)
Dec 2014
$19.63B(-15.5%)
$19.63B(-4.0%)
Sep 2014
-
$20.45B(-7.2%)
Jun 2014
-
$22.03B(+2.7%)
Mar 2014
-
$21.45B(-7.6%)
Dec 2013
$23.22B(-2.1%)
$23.22B(-0.1%)
Sep 2013
-
$23.25B(+0.1%)
Jun 2013
-
$23.22B(+4.1%)
Mar 2013
-
$22.29B(-6.1%)
Dec 2012
$23.73B(+2.1%)
$23.73B(+7.7%)
Sep 2012
-
$22.03B(+0.1%)
Jun 2012
-
$22.02B(+2.4%)
Mar 2012
-
$21.51B(-7.5%)
Dec 2011
$23.25B
$23.25B(-2.9%)
Sep 2011
-
$23.93B(+1.4%)
Jun 2011
-
$23.61B(+5.6%)
DateAnnualQuarterly
Mar 2011
-
$22.35B(-4.9%)
Dec 2010
$23.50B(+13.7%)
$23.50B(+6.2%)
Sep 2010
-
$22.13B(+0.2%)
Jun 2010
-
$22.09B(+6.6%)
Mar 2010
-
$20.73B(+0.3%)
Dec 2009
$20.66B(+29.8%)
$20.66B(+6.5%)
Sep 2009
-
$19.39B(+9.0%)
Jun 2009
-
$17.79B(+14.8%)
Mar 2009
-
$15.50B(-1.1%)
Dec 2008
$15.91B(+7.7%)
$15.67B(-2.9%)
Sep 2008
-
$16.13B(+1.1%)
Jun 2008
-
$15.96B(+8.2%)
Mar 2008
-
$14.75B(-0.2%)
Dec 2007
$14.78B(-3.4%)
$14.78B(+1.1%)
Sep 2007
-
$14.61B(-1.6%)
Jun 2007
-
$14.85B(+6.8%)
Mar 2007
-
$13.91B(-9.1%)
Dec 2006
$15.30B(+12.6%)
$15.30B(+4.2%)
Sep 2006
-
$14.68B(-1.6%)
Jun 2006
-
$14.92B(+9.8%)
Mar 2006
-
$13.58B(-0.1%)
Dec 2005
$13.60B(-5.6%)
$13.60B(+2.1%)
Sep 2005
-
$13.32B(-1.2%)
Jun 2005
-
$13.48B(-0.8%)
Mar 2005
-
$13.59B(-5.7%)
Dec 2004
$14.40B(+9.3%)
$14.40B(+8.0%)
Sep 2004
-
$13.34B(+5.0%)
Jun 2004
-
$12.71B(+3.5%)
Mar 2004
-
$12.27B(-6.9%)
Dec 2003
$13.18B(+18.0%)
$13.18B(-2.7%)
Sep 2003
-
$13.54B(+7.0%)
Jun 2003
-
$12.65B(+4.1%)
Mar 2003
-
$12.16B(+8.8%)
Dec 2002
$11.17B(+14.2%)
$11.17B(-3.8%)
Sep 2002
-
$11.62B(+10.9%)
Mar 2002
-
$10.48B(+7.1%)
Dec 2001
$9.79B(+2.8%)
$9.79B(-3.2%)
Sep 2001
-
$10.11B(+6.4%)
Jun 2001
-
$9.51B(-2.0%)
Mar 2001
-
$9.70B(+1.9%)
Dec 2000
$9.52B(+49.6%)
$9.52B(-12.3%)
Sep 2000
-
$10.85B(+2.3%)
Jun 2000
-
$10.61B(+11.3%)
Mar 2000
-
$9.53B(-7.5%)
Dec 1999
$6.37B(+52.2%)
$10.30B(-13.3%)
Sep 1999
-
$11.89B(+6.7%)
Jun 1999
-
$11.14B(+2.0%)
Dec 1998
$4.18B(+17.7%)
$10.93B(+168.9%)
Jun 1998
-
$4.06B(+13.8%)
Dec 1997
$3.55B(+2.1%)
$3.57B(+2.5%)
Dec 1996
$3.48B(+20.5%)
$3.48B(+21.1%)
Dec 1995
$2.89B(+9.6%)
$2.88B(-2.6%)
Jun 1995
-
$2.95B(+12.0%)
Dec 1994
$2.64B(+11.0%)
$2.63B(+18.8%)
Dec 1993
$2.37B(+639.5%)
$2.22B
Dec 1992
$321.05M(-59.0%)
-
Dec 1991
$782.20M(+37.1%)
-
Dec 1990
$570.69M
-

FAQ

  • What is AstraZeneca PLC annual stockholders equity?
  • What is the all time high annual shareholders equity for AstraZeneca PLC?
  • What is AstraZeneca PLC annual shareholders equity year-on-year change?
  • What is AstraZeneca PLC quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly shareholders equity year-on-year change?

What is AstraZeneca PLC annual stockholders equity?

The current annual shareholders equity of AZN is $40.79B

What is the all time high annual shareholders equity for AstraZeneca PLC?

AstraZeneca PLC all-time high annual stockholders equity is $40.79B

What is AstraZeneca PLC annual shareholders equity year-on-year change?

Over the past year, AZN annual stockholders equity has changed by +$1.64B (+4.20%)

What is AstraZeneca PLC quarterly stockholders equity?

The current quarterly shareholders equity of AZN is $44.72B

What is the all time high quarterly shareholders equity for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly stockholders equity is $44.72B

What is AstraZeneca PLC quarterly shareholders equity year-on-year change?

Over the past year, AZN quarterly stockholders equity has changed by +$5.21B (+13.18%)
On this page